Advertisement

Synthesis of anticancer compounds, III (Bioorg Med Chem Lett 17, 6091, 2007), carbinol derivatives of azanaphthoquinone annelated pyrroles

Original Paper

Abstract

A series of carbinols has been synthesized by attachment of different piperidinyl side chains to the quinone structure of azanaphthoquinone annelated pyrroles. The synthesized compounds were screened for their cytotoxic activities. Compared to previously published results, they exhibited only moderate activities, thus showing that the existence of the quinone moiety seems to be essential for anticancer activities of this group.

Graphical abstract

Keywords

Azanaphthoquinone Anticancer agents Heterocycles Carbinols 

Notes

Acknowledgments

N. Pongprom thanks The Royal Thai Government Scholarship for financial support throughout her PhD program.

References

  1. 1.
    Shanab K, Pongprom N, Wulz E, Holzer W, Spreitzer H, Schmidt P, Aicher B, Müller G, Günther E (2007) Bioorg Med Chem Lett Part II 17:6091CrossRefGoogle Scholar
  2. 2.
    Thuston DE, Lobo SGMJ (1998) In: Smith HJ (ed) Smith and Williams’ introduction to the principles of drug design and action. Harwood Academic Publishers, Amsterdam, p 331Google Scholar
  3. 3.
    Fox ME, Smith PJ (1990) Cancer Res 50:5813Google Scholar
  4. 4.
    Krapcho AP, Petry ME, Getahun Z, Landi JJ Jr, Stallman J, Polsenberg JF, Gallagher CE, Maresch MJ, Hacker MP (1994) J Med Chem 37:828CrossRefGoogle Scholar
  5. 5.
    Cavalletti E, Crippa L, Mainardi P, Oggioni N, Cavagnoli R, Bellini O, Sala F (2007) Invest New Drugs 25:187CrossRefGoogle Scholar
  6. 6.
    Spreitzer H, Pichler A, Holzer W, Kratzel M, Slanz R, Koulouri A, Krenn P, Parrer U, Szieberer P (2001) Heterocycles 54:111Google Scholar
  7. 7.
    Spreitzer H, Puschmann C (2007) Chem Mon 138:517CrossRefGoogle Scholar
  8. 8.
    Haider N (2002) J Heterocycl Chem 39:511CrossRefGoogle Scholar
  9. 9.
    Ram S, Spicer LD (1987) Tetrahedron Lett 28:515CrossRefGoogle Scholar
  10. 10.
    Birman VB, Chopra A, Ogle CA (1996) Tetrahedron Lett 37:5073CrossRefGoogle Scholar
  11. 11.
    Ashton MJ, Ashford A, Loveless AH, Riddell D, Salmon J, Stevenson GVW (1984) J Med Chem 27:1245CrossRefGoogle Scholar
  12. 12.
    Wei ZY, Brown W, Takasaki B, Plobeck N, Delorme D, Zhou F, Yang H, Jones P, Gawell L, Gagnon H, Schmidt R, Yue S, Walpole C, Payza K, St-Onge S, Labarre M, Godbout C, Jakob A, Butterworth J, Kamassah A, Morin PE, Projean D, Ducharme J, Roberts E (2000) J Med Chem 43:3895CrossRefGoogle Scholar
  13. 13.
    Kaiser C, Fowler PJ, Tedeschi DH, Lester BM, Garvey E, Zirkle CL (1974) J Med Chem 17:57CrossRefGoogle Scholar
  14. 14.
    Villani FJ, Mann TA, Welfer EA, Hannon J, Larca LL, Landon MJ, Spivak W, Vashi D (1975) J Med Chem 18:1CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  1. 1.Department of Drug and Natural Product SynthesisUniversity of ViennaViennaAustria
  2. 2.Zentaris GmbHDrug Discovery and Preclinical DevelopmentFrankfurtGermany

Personalised recommendations